Despina Televantou

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

Richard A. Noble, Natalie Bell, Helen J. Blair et al. · Haematologica · 2017 · 156 citations · Full text

Medicine, Oncology, Pharmacology +11

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

George Pentheroudakis, Vassiliki Kotoula, Wendy De Roock et al. · BMC Cancer · 2013 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

Georgios Iliadis, Vassiliki Kotoula, Athanasios Chatzisotiriou et al. · BMC Cancer · 2012 · 92 citations · Full text

Medicine, Oncology, Radiology +17

DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival

Liam Cornell, Joanne M. Munck, Clara Alsinet et al. · Clinical Cancer Research · 2014 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +17

Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression

Evangelia Razis, Konstantine T. Kalogeras, Vassiliki Kotoula et al. · Clinical Breast Cancer · 2012 · 57 citations

Medicine, Cancer Biology, Oncology +12